Frontline Forum Part 3: Topical Therapy for Corticosteroid-Responsive Dermatoses
Experts discuss enhancing patient outcomes, comparing clobetasol cream concentrations, and more.
Investigating Links Between Cancer and Psoriasis Management
Because of the chronic inflammatory state of psoriasis and the immunosuppression produced by some systemic medications, patients with psoriasis may have an increased risk of lymphoma and nonmelanoma skin cancer.
Frontline Forum Part 2: Topical Therapy for Corticosteroid-Responsive Dermatoses
Experts discuss enhancing patient outcomes, topical formulations and epidermal barrier dysfunction, and more.
Frontline Forum Part 1: Topical Therapy for Corticosteroid-Responsive Dermatoses
Experts discuss enhancing patient outcomes, the "mounting mutiny" against topicals, and more.
The ABCs of CBD: Cannabinoids in Dermatology and Skin Care
Cannabis-based personal care products suddenly seem ubiquitous all over the market, where CBD is a featured ingredient in everything from moisturizers and lotions to makeup.
Key Takeaways for the Management of Plaque Psoriasis
Experts in dermatology share final thoughts on the treatment of plaque psoriasis and the ever-changing treatment landscape.
Role of Diversity in Plaque Psoriasis Clinical Trials
Benjamin Lockshin, MD, FAAD, highlights diversity in clinical trials as an unmet need in approaching the treatment of plaque psoriasis.
Plaque Psoriasis Treatment Guidelines
Expert dermatologists discuss the treatment guidelines for plaque psoriasis, and how the decision about treatment is ultimately in the hands of the clinician.
Psychological Impact of Plaque Psoriasis
Nicholas Brownstone, MD, and James Q. Del Rosso, DO, comment on the psychological impact of plaque psoriasis on a patient’s quality of life.
Patient Case #3: 48-Year-Old Male With Plaque Psoriasis
Experts in dermatology review a patient case of a 48-year-old man with plaque psoriasis who is having trouble with topical therapy.
Patient Case #2: 60-Year-Old Female With Chronic Intertrigo
Dermatology experts discuss a patient case concerning a 60-year-old woman with chronic intertriginous psoriasis who is taking a biologic drug for inflammatory bowel disease.
Patient Case #1: 29-Year-Old Female With Plaque Psoriasis
Dawn L. Sammons, DO, FAOCD, FAAD, and Benjamin Lockshin, MD, FAAD, review a case of a female patient with a family history of plaque psoriasis.
Mechanism of Action of Tapinarof in Plaque Psoriasis
Experts discuss the unique mechanism of action of tapinarof and its use in the treatment of plaque psoriasis.
Efficacy of Tapinarof in Plaque Psoriasis
James Q. Del Rosso, DO, and Dawn L. Sammons, DO, FAOCD, FAAD, review the efficacy of a new topical agent in the treatment of plaque psoriasis, tapinarof, highlighting the remittive data.
Treatment Selection in Plaque Psoriasis
Experts in dermatology discuss newer topical treatments, such as tapinarof, in the management of plaque psoriasis.
Resident Training in Plaque Psoriasis
Nicholas Brownstone, MD, comments on how newer treatments in plaque psoriasis can impact residency training.
Topical vs Systemic Therapy in Plaque Psoriasis
Dawn L. Sammons, DO, FAOCD, FAAD, shares her approach to using topical vs systemic therapy in plaque psoriasis, focusing on patient preference as the driving factor for treatment selection.
Use of Topical Treatment in Plaque Psoriasis
Brad Glick, DO, FAOCD, highlights topical therapy as a targeted treatment of plaque psoriasis.
The Pathogenesis of Plaque Psoriasis
Benjamin Lockshin, MD, FAAD, comments on how the evolution of the pathophysiology of plaque psoriasis has led to more targeted therapies to treat the disease.
Alopecia’s Impact on Mental Health
Patients with chronic conditions like alopecia areata may experience a reciprocal relationship between their condition and mental health.
Dermatology Drug Pipeline 2023
Breakthroughs and approvals we can expect in the coming year.
Treatment of Vitiligo with Phototherapy
Phototherapy can serve an important role in the therapeutic armamentarium of vitiligo as it is safe, cost-effective, and can treat patients with large areas of disease.
Update on the Genetics of Vitiligo
Vitiligo can have a profound effect on mental health and quality of life.
Update on New Laser Treatments for Acne
Newly approved laser treatments can be an effective option for the treatment of this common skin disorder.
Surgical Treatment of Vitiligo
A recent systematic review on surgical therapies for vitiligo examined surgical therapies such as punch grafting, suction blister epidermal grafting, and cellular grafting techniques
The Psychosocial Impact of Vitiligo
Vitiligo, an autoimmune skin condition that causes depigmentation, can have a large effect on a patient’s quality of life and psychosocial well-being.
When to Progress to Systemic Therapy
Eric Simpson, MD, MCR, and professor of dermatology at Oregon Health & Science University presents exciting new systemic therapy treatment options for atopic dermatitis.
Acne Updates: Pearls on Treating Acne from a Recent Maui Derm Conference
Julie Harper, MD, a board-certified dermatologist in private practice in Birmingham, Alabama, a founding director and past president of the American Acne and Rosacea Society, gave a presentation on acne treatment updates at the Maui Derm NP+PA Summer 2022 conference.
How Personalized Medicine Has the Potential to Revolutionize Dermatology
Recent advances in technology have begun to allow the realization of personalized medicine in the practice of dermatology.
Elevate Cutaneous Oncology
George Martin, MD and Ted Rosen, MD gave a 2-part comprehensive presentation on the changing landscape of cutaneous oncology at Maui Derm NP + PA Summer 2022.
2 Clarke Drive Cranbury, NJ 08512